Ignite Creation Date:
2025-12-24 @ 1:28 PM
Ignite Modification Date:
2026-04-21 @ 11:18 AM
Study NCT ID:
NCT01440595
Status:
TERMINATED
Last Update Posted:
2024-05-22
First Post:
2011-09-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Grazoprevir (MK-5172) With Peg-Interferon and Ribavirin in Participants With Chronic Genotype 2 or 3 Hepatitis C (MK-5172-012)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
5172-012
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None